[HTML][HTML] Monoclonal antibodies in the treatment of relapsing multiple sclerosis: an overview with emphasis on pregnancy, vaccination, and risk management
N Krajnc, G Bsteh, T Berger, J Mares, HP Hartung - Neurotherapeutics, 2022 - Elsevier
Monoclonal antibodies have become a mainstay in the treatment of patients with relapsing
multiple sclerosis (RMS) and provide some benefit to patients with primary progressive MS …
multiple sclerosis (RMS) and provide some benefit to patients with primary progressive MS …
[HTML][HTML] Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management
N Krajnc, G Bsteh, T Berger, J Mares… - …, 2022 - ncbi.nlm.nih.gov
Monoclonal antibodies have become a mainstay in the treatment of patients with relapsing
multiple sclerosis (RMS) and provide some benefit to patients with primary progressive MS …
multiple sclerosis (RMS) and provide some benefit to patients with primary progressive MS …
Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management
N Krajnc, G Bsteh, T Berger, J Mares… - …, 2022 - search.proquest.com
Monoclonal antibodies have become a mainstay in the treatment of patients with relapsing
multiple sclerosis (RMS) and provide some benefit to patients with primary progressive MS …
multiple sclerosis (RMS) and provide some benefit to patients with primary progressive MS …
Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management.
N Krajnc, G Bsteh, T Berger, J Mares… - …, 2022 - search.ebscohost.com
Monoclonal antibodies have become a mainstay in the treatment of patients with relapsing
multiple sclerosis (RMS) and provide some benefit to patients with primary progressive MS …
multiple sclerosis (RMS) and provide some benefit to patients with primary progressive MS …
[HTML][HTML] Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management
N Krajnc, G Bsteh, T Berger, J Mares, HP Hartung - Neurotherapeutics, 2022 - Springer
Monoclonal antibodies have become a mainstay in the treatment of patients with relapsing
multiple sclerosis (RMS) and provide some benefit to patients with primary progressive MS …
multiple sclerosis (RMS) and provide some benefit to patients with primary progressive MS …
[PDF][PDF] Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management
N Krajnc, G Bsteh, T Berger, J Mares, HP Hartung - 2022 - academia.edu
Monoclonal antibodies have become a mainstay in the treatment of patients with relapsing
multiple sclerosis (RMS) and provide some benefit to patients with primary progressive MS …
multiple sclerosis (RMS) and provide some benefit to patients with primary progressive MS …
Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management
N Krajnc, G Bsteh, T Berger… - … : the journal of the …, 2022 - pubmed.ncbi.nlm.nih.gov
Monoclonal antibodies have become a mainstay in the treatment of patients with relapsing
multiple sclerosis (RMS) and provide some benefit to patients with primary progressive MS …
multiple sclerosis (RMS) and provide some benefit to patients with primary progressive MS …
Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management.
N Krajnc, G Bsteh, T Berger, J Mares… - … : the Journal of the …, 2022 - europepmc.org
Monoclonal antibodies have become a mainstay in the treatment of patients with relapsing
multiple sclerosis (RMS) and provide some benefit to patients with primary progressive MS …
multiple sclerosis (RMS) and provide some benefit to patients with primary progressive MS …
[HTML][HTML] Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management
N Krajnc, G Bsteh, T Berger, J Mares… - …, 2022 - neurotherapeuticsjournal.org
Monoclonal antibodies have become a mainstay in the treatment of patients with relapsing
multiple sclerosis (RMS) and provide some benefit to patients with primary progressive MS …
multiple sclerosis (RMS) and provide some benefit to patients with primary progressive MS …
[引用][C] Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management
N Krajnc, G Bsteh, T Berger, J Mares, HP Hartung - Neurotherapeutics, 2022 - cir.nii.ac.jp
Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with
Emphasis on Pregnancy, Vaccination, and Risk Management | CiNii Research CiNii 国立情報学 …
Emphasis on Pregnancy, Vaccination, and Risk Management | CiNii Research CiNii 国立情報学 …